BCM
ACRS icon

Bayesian Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bayesian Capital Management’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,800
Closed -$18.7K – 753
2023
Q4 		$18.7K Buy
+17,800
New +$18.7K ﹤0.01% 696